VENOUS SEQUENCE FOLLOWING ETOMIDATE

Open Access
Publisher Website
Google Scholar
Abstract
Five hundred patients receiving one of three different formulations of etomidate were observed on the 2rd and 3rd days after operation for possible venous sequelae. The total frequency of sequelae was 8% or more, the greatest being with the propylene glycol formulation (23%) Formulation of the drug and total dose employed were the most important factors influencing venous sequence, which were not related to pain or injection.

This publication has 0 references indexed in Scilit: